Dermatology TextbookGenerating differential diagnosisPart C Differential Diagnosis

Differential Diagnosis of Vesicles and Bullae

Introduction

Vesicles (fluid-filled blisters <1cm) and bullae (≥1cm) represent separation within or below the epidermis due to various pathological processes. The diagnostic approach centers on determining the level of the split (intraepidermal vs. subepidermal), which correlates with blister characteristics and underlying etiology. This distinction guides differential diagnosis and investigation.

Understanding the ultrastructure of the epidermis and basement membrane zone (BMZ) is essential, as autoimmune blistering diseases target specific antigens at different levels.


27.1 Anatomy of the Blistering Target

27.1.1 Intraepidermal Targets

LevelStructuresAntigens TargetedDisease
Stratum CorneumSuperficial cleavageExfoliative toxins (ETA/ETB)SSSS, Bullous Impetigo
Stratum GranulosumDesmosomes (Desmoglein 1)Dsg1Pemphigus Foliaceus
SuprabasalDesmosomes (Desmoglein 3 ± Dsg1)Dsg3Pemphigus Vulgaris

27.1.2 Subepidermal Targets (Basement Membrane Zone)

LevelStructuresAntigens TargetedDisease
Lamina LucidaHemidesmosomesBP180, BP230Bullous Pemphigoid, Pemphigoid Gestationis
Lamina DensaType IV CollagenCollagen IV (α3 chain)Anti-Laminin-332 Pemphigoid
Sublamina DensaAnchoring FibrilsType VII CollagenEpidermolysis Bullosa Acquisita, Bullous SLE
Dermal Papillae-Tissue Transglutaminase, EndomysiumDermatitis Herpetiformis

27.2 Clinical Differentiation: Flaccid vs. Tense Blisters

FeatureIntraepidermal (Flaccid)Subepidermal (Tense)
Blister AppearanceThin-roofed, rupture easily, often present as erosionsThick-roofed, intact, dome-shaped
Nikolsky SignPositive (skin shears with lateral pressure)Negative
Asboe-Hansen SignExtension of blister with pressureNot typically seen
ExamplesPemphigus, SSSS, HerpesBullous Pemphigoid, EBA, DH

27.3 Causes of Intraepidermal Blisters (Flaccid)

27.3.1 Pemphigus Vulgaris (PV)

  • Definition: Autoimmune disease with IgG antibodies against desmoglein 3 (Dsg3), a desmosomal cadherin in the suprabasal epidermis.
  • Epidemiology: Middle-aged adults (40-60 years). Higher incidence in Ashkenazi Jews and Mediterranean populations.
  • Clinical Features:
    • Oral Involvement: Often the FIRST and MOST PERSISTENT site. Painful erosions on buccal mucosa, palate, gums. May precede skin lesions by months.
    • Cutaneous Lesions: Flaccid blisters on normal or erythematous skin. Rupture easily → painful erosions.
    • Distribution: Trunk, scalp, face, intertriginous areas.
    • Nikolsky Sign: Positive.
  • Pathophysiology: Anti-Dsg3 (± anti-Dsg1) → Loss of keratinocyte adhesion (acantholysis) → Suprabasal split.
  • Histopathology: Suprabasal acantholysis. "Tombstone" appearance (basal keratinocytes remain attached to basement membrane).
  • Direct Immunofluorescence (DIF): "Chicken-wire" or "fish-net" pattern of IgG and C3 on intercellular spaces throughout the epidermis.
  • Indirect IF / ELISA: Circulating anti-Dsg3 (± anti-Dsg1) antibodies.
  • Prognosis: Untreated = high mortality. Requires systemic immunosuppression (steroids, Rituximab).

27.3.2 Pemphigus Foliaceus (PF)

  • Definition: Autoimmune disease with IgG antibodies against desmoglein 1 (Dsg1).
  • Clinical Features:
    • No Mucosal Involvement (Dsg1 is expressed weakly in oral mucosa, compensated by Dsg3).
    • Superficial Blisters: Very superficial, rupture instantly → scaly, crusted erosions ("corn flakes-like" scale).
    • Distribution: Seborrheic distribution (face, scalp, upper trunk).
  • Endemic Form (Fogo Selvagem): Found in rural Brazil. Linked to insect bites (black fly).
  • Histopathology: Subcorneal/Granular layer acantholysis.
  • DIF: Intercellular IgG/C3 (similar to PV but more superficial).
  • Prognosis: Better than PV. Less mortality.

27.3.3 Staphylococcal Scalded Skin Syndrome (SSSS)

[!IMPORTANT] Pediatric Emergency

  • Definition: Exfoliative toxin-mediated (ETA, ETB) blistering disease caused by Staphylococcus aureus (Phage group II).
  • Age: Primarily neonates and children <5 years (adults rarely affected, usually with renal impairment as toxin is renally excreted).
  • Pathogenesis: Exfoliative toxins cleave desmoglein 1 → Superficial split at stratum granulosum.
  • Clinical Features:
    • Fever, irritability.
    • Diffuse, tender erythema ("scalded" appearance).
    • Flaccid blisters that rupture easily → Widespread erosions.
    • Nikolsky Sign: Positive.
    • Mucous Membranes SPARED (unlike TEN).
    • Perioral radial crusting.
  • Histopathology: Subcorneal split WITHOUT necrosis (cleavage superficial).
  • Differentiation from TEN:
    • SSSS: Superficial split, NO mucosal involvement, Child, Culture positive (distant site).
    • TEN: Full-thickness epidermal necrosis, Mucosal involvement, Drug history, Adult.
  • Treatment: IV anti-staphylococcal antibiotics (Flucloxacillin, Clindamycin). Supportive skin care.

27.3.4 Viral Vesicular Diseases

Herpes Simplex Virus (HSV)

  • Primary Infection: More severe. Grouped vesicles on erythematous base, may have systemic symptoms.
  • Recurrent Infection: Classic "cold sores" (orolabial HSV-1) or genital herpes (HSV-2).
  • Morphology: Grouped vesicles on erythematous base ("dew drops on a rose petal"). Umbilicated vesicles may be seen.
  • Tzanck Smear: Multinucleated giant cells, ballooning degeneration.
  • Diagnosis: PCR (gold standard), Direct Fluorescent Antibody (DFA), Viral culture.

Varicella-Zoster Virus (VZV)

  • Varicella (Chickenpox): Generalized vesicles in "all stages" (papules, vesicles, pustules, crusts). Centripetal distribution.
  • Herpes Zoster (Shingles): Reactivation. Dermatomal distribution, unilateral. Preceded by pain (prodrome).

Eczema Herpeticum

[!CAUTION] DERMATOLOGIC EMERGENCY

  • Definition: Disseminated HSV infection in patients with pre-existing skin disease (atopic dermatitis most common).
  • Clinical Features: Sudden onset of monomorphic, punched-out erosions and vesicles on eczematous skin. Fever, malaise.
  • Risk: Viremia, encephalitis, death.
  • Treatment: IV Acyclovir urgently.

27.4 Causes of Subepidermal Blisters (Tense)

27.4.1 Bullous Pemphigoid (BP)

  • Definition: Most common autoimmune blistering disease. IgG antibodies against hemidesmosomal proteins BP180 (BPAG2, Collagen XVII) and BP230 (BPAG1).
  • Epidemiology: Elderly patients (>60 years). Incidence increasing with aging population.
  • Clinical Features:
    • Prodromal Phase: Weeks to months of pruritus with urticarial or eczematous lesions BEFORE blisters appear.
    • Bullous Phase: Large, tense, dome-shaped blisters on erythematous or normal skin.
    • Distribution: Trunk, flexural areas (axillae, groin, inner thighs), extremities.
    • Mucosal Involvement: Rare (<10-20%).
    • Pruritus: Often severe.
  • Nikolsky Sign: Negative.
  • Histopathology: Subepidermal blister. Eosinophil-rich infiltrate in dermis.
  • Direct Immunofluorescence (DIF): Linear IgG and C3 at the basement membrane zone (BMZ).
  • Indirect IF (Salt-Split Skin): Antibodies bind to the EPIDERMAL (roof) side of the split.
  • ELISA: Anti-BP180 NC16A, Anti-BP230. Titers correlate with disease activity.
  • Treatment: Potent topical steroids (mild/moderate), Systemic steroids + steroid-sparing agents (severe).

27.4.2 Dermatitis Herpetiformis (DH)

  • Definition: Intensely pruritic, vesicular eruption strongly associated with Celiac disease (gluten-sensitive enteropathy).
  • Epidemiology: Young to middle-aged adults. Male predominance. Associated with HLA-DQ2/DQ8.
  • Clinical Features:
    • Morphology: Grouped papulovesicles on erythematous base. Intensely pruritic.
    • Distribution: Extensor surfaces (elbows, knees), buttocks, sacrum, scalp.
    • Symmetry: Symmetric.
    • Vesicles often excoriated (so may present as erosions/crusts rather than intact vesicles due to scratching).
  • Histopathology: Subepidermal blister. Neutrophils in dermal papillae (neutrophilic microabscesses).
  • Direct Immunofluorescence (DIF): GRANULAR IgA deposits at dermal papillae (PATHOGNOMONIC).
  • Celiac Association: >90% have celiac disease (often asymptomatic GI-wise). Screen with tissue transglutaminase (tTG) IgA, endomysial antibodies.
  • Treatment: Lifelong GLUTEN-FREE DIET (treats both skin and gut). Dapsone for rapid symptom control.

27.4.3 Epidermolysis Bullosa Acquisita (EBA)

  • Definition: Autoimmune disease with IgG antibodies against Type VII Collagen (anchoring fibrils in sublamina densa).
  • Clinical Features:
    • Mechanobullous Presentation: Trauma-induced blisters on acral areas (hands, feet, elbows, knees). Heal with scarring and milia.
    • Inflammatory Presentation: Can mimic Bullous Pemphigoid.
  • DIF: Linear IgG at BMZ.
  • Indirect IF (Salt-Split Skin): Antibodies bind to the DERMAL (floor) side of the split (differentiates from BP).
  • Association: Inflammatory bowel disease (especially Crohn's).

27.4.4 Linear IgA Bullous Dermatosis (LABD)

  • Epidemiology: Bimodal (children = "Chronic Bullous Disease of Childhood"; adults = often drug-induced).
  • Clinical Features:
    • Tense blisters, often in "string of pearls" or "cluster of jewels" arrangement (annular configuration).
    • Mucosal involvement common.
    • Drug-induced: Vancomycin is classic culprit.
  • DIF: Linear IgA at BMZ.

27.5 Life-Threatening Blistering Emergencies

[!CAUTION] Emergencies Requiring Immediate Action

Stevens-Johnson Syndrome (SJS) / Toxic Epidermal Necrolysis (TEN)

  • Definition: Severe, drug-induced mucocutaneous reaction with epidermal necrosis.
    • SJS: <10% BSA detachment.
    • SJS/TEN Overlap: 10-30% BSA.
    • TEN: >30% BSA.
  • Drugs: Sulfonamides, Anticonvulsants (Carbamazepine, Phenytoin, Lamotrigine), Allopurinol, NSAIDs (Piroxicam), Nevirapine.
  • Clinical Features:
    • Prodrome: Fever, malaise, sore throat.
    • Skin: Atypical target lesions with central necrosis (dusky center), coalescing purpuric macules, widespread epidermal sloughing.
    • Mucosal Involvement: Oral, ocular, genital. Painful erosions.
    • Nikolsky Sign: Positive.
    • Skin Pain: Out of proportion to appearance.
  • Histopathology: Full-thickness epidermal necrosis with subepidermal split.
  • SCORTEN: Prognostic scoring system (Age, Malignancy, BSA, Tachycardia, BUN, Glucose, Bicarbonate).
  • Management: Stop offending drug. ICU/Burns unit care. Supportive. Cyclosporine may reduce mortality.

27.6 Diagnostic Algorithm

Loading diagram...

27.7 Summary Comparison Table

DiseaseBlisterOralNikolskyLevelDIF PatternTarget Antigen
Pemphigus VulgarisFlaccidYes+SuprabasalChicken-wire IgGDsg3 (± Dsg1)
Pemphigus FoliaceusFlaccidNo+SubcornealChicken-wire IgGDsg1
SSSSFlaccidNo+SubcornealNegativeDsg1 (toxin-mediated)
Bullous PemphigoidTenseRare-SubepidermalLinear IgG/C3 (epidermal)BP180, BP230
Dermatitis HerpetiformisTense/GroupedNo-SubepidermalGranular IgA (papillae)Tissue Transglutaminase
EBATenseVariable-SubepidermalLinear IgG (dermal)Type VII Collagen
LABDTenseYes-SubepidermalLinear IgABP180, others
TEN/SJSFlaccid/NecroticYes+Full-thickness necrosisNegative- (Drug-induced)

27.8 Clinical Pearls

  1. Flaccid blisters with oral erosions → Think Pemphigus Vulgaris. Biopsy for DIF.
  2. Tense blisters in elderly with pruritus → Bullous Pemphigoid. Anti-BP180 ELISA.
  3. Intensely pruritic grouped vesicles on extensors → Dermatitis Herpetiformis. Check for Celiac (tTG IgA).
  4. Scalded appearance in child, NO mucosal involvement → SSSS. IV Antibiotics.
  5. Mucosal involvement + Skin necrosis + Drug history → TEN/SJS. Stop drug. ICU.
  6. Salt-split skin: Epidermal binding = BP, LABD. Dermal binding = EBA, Bullous SLE.
  7. "String of pearls" blisters + Vancomycin → Linear IgA Bullous Dermatosis.

How to Cite

Cutisight. "Vesicles Bullae." Encyclopedia of Dermatology [Internet]. 2026. Available from: https://cutisight.com/education/volume-04-generating-differential-diagnosis/part-c-differential-diagnosis/27-vesicles-bullae

This is an open-access resource. Please cite appropriately when using in academic or clinical work.